Analysts Set Kemper Co. (NYSE:KMPR) Price Target at $80.40

Shares of Kemper Co. (NYSE:KMPR) have been assigned a consensus rating of “Buy” from the five ratings firms that are currently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $80.40.

KMPR has been the subject of a number of research reports. JMP Securities reissued a “market outperform” rating and set a $85.00 target price on shares of Kemper in a research report on Tuesday, October 15th. Raymond James increased their price objective on Kemper from $75.00 to $82.00 and gave the company a “strong-buy” rating in a report on Thursday, December 26th. TD Cowen boosted their target price on Kemper from $72.00 to $84.00 and gave the company a “buy” rating in a research note on Tuesday, November 19th. Finally, StockNews.com raised Kemper from a “hold” rating to a “buy” rating in a report on Tuesday, January 7th.

Institutional Investors Weigh In On Kemper

A number of institutional investors and hedge funds have recently modified their holdings of the company. GAMMA Investing LLC increased its holdings in Kemper by 114.7% during the 3rd quarter. GAMMA Investing LLC now owns 541 shares of the insurance provider’s stock worth $33,000 after acquiring an additional 289 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Kemper by 5,590.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 569 shares of the insurance provider’s stock worth $35,000 after buying an additional 559 shares in the last quarter. Quarry LP boosted its stake in Kemper by 105.1% during the second quarter. Quarry LP now owns 642 shares of the insurance provider’s stock valued at $38,000 after buying an additional 329 shares during the period. Clean Yield Group purchased a new position in Kemper during the fourth quarter worth about $45,000. Finally, Capital Performance Advisors LLP bought a new position in Kemper in the 3rd quarter worth about $46,000. 86.23% of the stock is owned by hedge funds and other institutional investors.

Kemper Stock Performance

Shares of KMPR opened at $65.40 on Friday. The stock has a 50 day moving average of $67.28 and a 200 day moving average of $64.14. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of 15.57 and a beta of 0.88. Kemper has a 12 month low of $54.11 and a 12 month high of $73.01. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 0.50.

Kemper (NYSE:KMPR) last released its earnings results on Wednesday, October 30th. The insurance provider reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.28. The company had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Kemper had a return on equity of 12.03% and a net margin of 5.86%. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.44) EPS. As a group, sell-side analysts forecast that Kemper will post 5.36 earnings per share for the current year.

Kemper Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 4th. Shareholders of record on Monday, November 18th were paid a $0.31 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.24 annualized dividend and a yield of 1.90%. Kemper’s dividend payout ratio is currently 29.52%.

Kemper Company Profile

Kemper Corporation, a diversified insurance holding company, engages in the provision of insurance products to individuals and businesses in the United States. The company operates through three segments: Specialty Property & Casualty Insurance, Preferred Property & Casualty Insurance, and Life & Health Insurance.